Verrica Pharmaceuticals (VRCA) Earnings Date, Estimates & Call Transcripts $0.64 +0.02 (+2.66%) As of 11:39 AM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Verrica Pharmaceuticals Earnings Summary Verrica Pharmaceuticals announced Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.10, which topped the consensus estimate of -$0.14 by $0.04. Quarterly revenue was reported to be $3.44 million, above analyst estimates of $2.53 million. With a trailing EPS of -$1.20, Verrica Pharmaceuticals' earnings are expected to grow next year, from ($1.46) to ($0.74) per share. Upcoming Q2 Earnings DateAug. 13Before Market OpensEstimatedConsensus EPS (May. 13) -$0.14 Actual EPS (May. 13) -$0.10 Beat By $0.04 Actual Revenue (May. 13) $3.44MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)VRCA Upcoming EarningsVerrica Pharmaceuticals' next earnings date is estimated for Wednesday, August 13, 2025, based on past reporting schedules. Powered by Get Verrica Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Verrica Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVRCA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VRCA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Verrica Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.10-$0.10-$0.10Q2 20252-$0.09-$0.07-$0.08Q3 20252-$0.07-$0.06-$0.07Q4 20252-$0.06-$0.02-$0.04 Verrica Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/13/2025(Estimated)--------5/13/2025Q1 2025-$0.14-$0.10+$0.04-$0.10$2.53M$3.44M3/11/2025Q4 2024-$0.25-$0.24+$0.01-$0.24$1.30M$0.34M11/4/2024--$0.37-$0.49 -$0.12-$0.49$7.53M-$1.78M8/14/2024Q2 2024-$0.43-$0.37+$0.06-$0.37$4.70M$5.18M5/13/2024Q1 2024-$0.54-$0.44+$0.10-$0.44$2.70M$3.83M2/29/2024Q4 2023-$0.47-$0.48 -$0.01-$0.43$1.10M$1.99M11/9/2023Q3 2023-$0.22-$0.32 -$0.10-$0.10$1.12M$2.92M8/8/2023Q2 2023-$0.22-$0.24 -$0.02-$0.24-$0.18M Verrica Pharmaceuticals Earnings - Frequently Asked Questions When is Verrica Pharmaceuticals's earnings date? Verrica Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 13th, 2025 based off last year's report dates. Learn more on VRCA's earnings history. Did Verrica Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Verrica Pharmaceuticals (NASDAQ:VRCA) reported ($0.10) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.14) by $0.04. Learn more on analysts' earnings estimate vs. VRCA's actual earnings. How can I listen to Verrica Pharmaceuticals's earnings conference call? The conference call for Verrica Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Verrica Pharmaceuticals's conference call transcript? The conference call transcript for Verrica Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Verrica Pharmaceuticals generate each year? Verrica Pharmaceuticals (NASDAQ:VRCA) has a recorded annual revenue of $7.18 million. How much profit does Verrica Pharmaceuticals generate each year? Verrica Pharmaceuticals (NASDAQ:VRCA) has a recorded net income of -$67 million. VRCA has generated -$1.20 earnings per share over the last four quarters. What is Verrica Pharmaceuticals's EPS forecast for next year? Verrica Pharmaceuticals's earnings are expected to grow from ($1.46) per share to ($0.74) per share in the next year. More Earnings Resources from MarketBeat Related Companies SCPH Earnings Results FDMT Earnings Results PRME Earnings Results KOD Earnings Results BTMD Earnings Results CRGX Earnings Results CTMX Earnings Results MNPR Earnings Results ACIU Earnings Results SOPH Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:VRCA) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verrica Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Verrica Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VRCA Stock Free VRCA Stock Alerts